Osteoporosis International

, Volume 18, Issue 11, pp 1473–1480

Osteoporosis practice patterns in 2006 among primary care physicians participating in the NORA study

  • T. W. Weiss
  • E. S. Siris
  • E. Barrett-Connor
  • P. D. Miller
  • C. A. McHorney
Original Article

Abstract

Summary

This study investigated osteoporosis management trends from 1998 to 2006 among 808 primary care physicians involved in the US-based NORA (National Osteoporosis Risk Assessment) study. These results suggest some significant improvements in osteoporosis management over the past eight years.

Introduction

The purpose of this study was to investigate osteoporosis management trends among a large cohort of primary care physicians (PCPs) involved in the US-based NORA (National Osteoporosis Risk Assessment) study.

Methods

In 2006, we undertook a resurvey of the 2,836 NORA PCPs who completed a baseline survey in 1998. Of the 2,199 PCPs for whom we had current contact information and who were still practicing, we collected usable surveys from 808 (37% response rate).

Results

From 1998 to 2006, more than double the percentage of NORA PCPs reported using BMDs “often” (35% vs. 87%). There was a doubling of the percentage of NORA PCPs who reported that a T-score of ≤ −2.5 was the threshold indicating the presence of osteoporosis (34% vs. 67%). The percentage of NORA PCPs who reported using bone turnover markers to screen, diagnosis, or monitor osteoporosis almost tripled (19% vs. 55%). The percentage of patients prescribed or recommended hormone therapy dropped sixfold (67% to 11%), and the percentage of patients prescribed bisphosphonates increased fourfold from 15% to 59%.

Conclusion

These results suggest some significant improvements in osteoporosis management over the past eight years.

Keywords

Osteoporosis Physician’s practice patterns Postmenopausal Primary health care 

References

  1. 1.
    Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW et al (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 9(6):544–564PubMedGoogle Scholar
  2. 2.
    Morris AH, Zuckerman JD (2002) National consensus conference on improving the continuum of care for patients with hip fracture. J Bone Joint Surg Am 84-A(4):670–674PubMedGoogle Scholar
  3. 3.
    North American Menopause Society (2002) Management of postmenopausal osteoporosis: position statement of the North American Menopause Society. Menopause 9(2):84–101Google Scholar
  4. 4.
    National Osteoporosis Foundation (2003) Physician’s guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DCGoogle Scholar
  5. 5.
    NIH Consensus Development Panel on Osteoporosis Prevention Diagnosis, and Therapy (2001) Osteoporosis prevention, diagnosis, and therapy. JAMA 285(6):785–795CrossRefGoogle Scholar
  6. 6.
    US Preventive Services Task Force (2002) Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 137(6):526–528Google Scholar
  7. 7.
    US Department of Health and Human Services (2004) Bone health and osteoporosis: a report of the surgeon general. US Department of Health and Human Services, Office of the Surgeon General, Rockville, MDGoogle Scholar
  8. 8.
    National Osteoporosis Foundation. National Osteoporosis Foundation [Web Page]. Available at http://www.nof.org/osteoporosis/diseasefacts.htm. (Accessed 2006 Nov 7)
  9. 9.
    Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A (2007) Incidence and economic burden of osteoporosis-related fractures in the United States, 2005–2025. J Bone Miner Res 22(3):465–475PubMedCrossRefGoogle Scholar
  10. 10.
    Solomon DH, Morris C, Cheng H, Cabral D, Katz JN, Finkelstein JS et al (2005) Medication use patterns for osteoporosis: an assessment of guidelines, treatment rates, and quality improvement interventions. Mayo Clin Proc 80(2):194–202PubMedGoogle Scholar
  11. 11.
    Holick MF, Siris ES, Binkley N, Beard MK, Khan A, Katzer JT et al (2005) Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 90(6):3215–3224PubMedCrossRefGoogle Scholar
  12. 12.
    Lips P, Hosking D, Lippuner K, Norquist JM, Wehren L, Maalouf G et al (2006) The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 260(3):245–254PubMedCrossRefGoogle Scholar
  13. 13.
    Miller PD (2005) Bone density and markers of bone turnover in predicting fracture risk and how changes in these measures predict fracture risk reduction. Curr Osteoporos Rep 3(3):103–110PubMedCrossRefGoogle Scholar
  14. 14.
    Miller PD, Hochberg MC, Wehren LE, Ross PD, Wasnich RD (2005) How useful are measures of BMD and bone turnover? Curr Med Res Opin 21(4):545–554PubMedCrossRefGoogle Scholar
  15. 15.
    Bonnick SL, Shulman L (2006) Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both? Am J Med 119(4 Suppl 1):S25–S31PubMedCrossRefGoogle Scholar
  16. 16.
    Suarez-Almazor M, Homik JE, Messina D, Davis P (1997) Attitudes and beliefs of family physicians and gynecologists in relation to the prevention and treatment of osteoporosis. J Bone Miner Res 12(7):1100–1107PubMedCrossRefGoogle Scholar
  17. 17.
    Romagnoli E, Colangeli I, Minisola S (2000) Awareness, attitudes and opinions on osteoporosis of primary care physicians working in the metropolitan area of Rome: a brief report. Aging (Milano) 12(3):240–244Google Scholar
  18. 18.
    Werner P, Vered I (2000) Management of osteoporosis: a survey of Israeli physicians’ knowledge and attitudes. Isr Med Assoc J 2(5):361–364PubMedGoogle Scholar
  19. 19.
    Jaglal SB, McIsaac WJ, Hawker G, Carroll J, Jaakkimainen L, Cadarette SM et al (2003) Information needs in the management of osteoporosis in family practice: an illustration of the failure of the current guideline implementation process. Osteoporos Int 14(8):672–676PubMedCrossRefGoogle Scholar
  20. 20.
    Perez-Edo L, Recasens M, Castelo-Branco C, Lopez P, Marques A, Perez C et al (2004) Management of osteoporosis in general practice: a cross-sectional survey of primary care practitioners in Spain. Osteoporos Int 15:252–257PubMedCrossRefGoogle Scholar
  21. 21.
    Dreinhofer KE, Anderson M, Feron JM, Herrera A, Hube R, Johnell O et al (2005) Multinational survey of osteoporotic fracture management. Osteoporos Int 16 (Suppl 2):S44–S53PubMedCrossRefGoogle Scholar
  22. 22.
    Fleming R, Patrick K (2002) Osteoporosis prevention: pediatricians’ knowledge, attitudes, and counseling practices. Prev Med 34(4):411–421PubMedCrossRefGoogle Scholar
  23. 23.
    Skedros JG, Holyoak JD, Pitts TC (2006) Knowledge and opinions of orthopaedic surgeons concerning medical evaluation and treatment of patients with osteoporotic fracture. J Bone Joint Surg Am 88(1):18–24PubMedCrossRefGoogle Scholar
  24. 24.
    Simonelli C, Killeen K, Mehle S, Swanson L (2002) Barriers to osteoporosis identification and treatment among primary care physicians and orthopedic surgeons. Mayo Clin Proc 77(4):334–338PubMedCrossRefGoogle Scholar
  25. 25.
    Solomon DH, Connelly MT, Rosen CJ, Dawson-Hughes B, Kiel DP, Greenspan SL et al (2003) Factors related to the use of bone densitometry: survey responses of 494 primary care physicians in New England. Osteoporos Int 14(2):123–129PubMedGoogle Scholar
  26. 26.
    Siris E, Miller P, Barrett-Connor E, Abbott T, Sherwood L, Berger M (1998) Design of NORA, the National Osteoporosis Risk Assessment Program: a longitudinal US registry of postmenopausal women. Osteoporos Int 8 (Suppl 1):S62–S69PubMedGoogle Scholar
  27. 27.
    Siris ES, Miller PD, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA et al (2001) Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the national osteoporosis risk assessment. JAMA 200;286(22):2815–2822Google Scholar
  28. 28.
    Jaglal SB, McIsaac WJ, Hawker G, Jaakkimainen L, Cadarette SM, Chan BT (2000) Patterns of use of the bone mineral density test in Ontario, 1992–1998. CMAJ 163(9):1139–1143PubMedGoogle Scholar
  29. 29.
    Jaglal SB, Weller I, Mamdani M, Hawker G, Kreder H, Jaakkimainen L et al (2005) Population trends in BMD testing, treatment, and hip and wrist fracture rates: are the hip fracture projections wrong? J Bone Miner Res 20(6):898–905PubMedCrossRefGoogle Scholar
  30. 30.
    Perreault S, Dragomir A, Desgagne A, Blais L, Rossignol M, Blouin J et al (2005) Trends and determinants of antiresorptive drug use for osteoporosis among elderly women. Pharmacoepidemiol Drug Saf 14(10):685–695PubMedCrossRefGoogle Scholar
  31. 31.
    Miller PD, Siris ES, Barrett-Connor E, Faulkner KG, Wehren LE, Abbott TA et al (2002) Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J Bone Miner Res 17(12):2222–2230PubMedCrossRefGoogle Scholar
  32. 32.
    Melton LJ 3rd, Crowson CS, O’Fallon WM, Wahner HW, Riggs BL (2003) Relative contributions of bone density, bone turnover, and clinical risk factors to long-term fracture prediction. J Bone Miner Res 18(2):312–318PubMedCrossRefGoogle Scholar
  33. 33.
    Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, Delmas P et al (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20(7):1185–1194PubMedCrossRefGoogle Scholar
  34. 34.
    Feldstein A, Elmer PJ, Orwoll E, Herson M, Hillier T (2003) Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures: a gap in evidence–based practice guideline implementation. Arch Intern Med 163(18):2165–2172PubMedCrossRefGoogle Scholar
  35. 35.
    Giangregorio L, Papaioannou A, Cranney A, Zytaruk N, Adachi JD (2006) Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin Arthritis Rheum 35(5):293–305PubMedCrossRefGoogle Scholar
  36. 36.
    Looker AC, Bauer DC, Chesnut CH 3rd, Gundberg CM, Hochberg MC, Klee G et al (2000) Clinical use of biochemical markers of bone remodeling: current status and future directions. Osteoporos Int 11(6):467–480PubMedCrossRefGoogle Scholar
  37. 37.
    Garnero P, Delmas PD (2004) Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. J Musculoskelet Neuronal Interact 4(1):50–63PubMedGoogle Scholar
  38. 38.
    Austin P, Tu K (2003) Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women’s Health Initiative. JAMA 289(24):3241–3242PubMedCrossRefGoogle Scholar
  39. 39.
    Hersh AL, Stefanick ML, Stafford RS (2004) National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA 291(1):47–53PubMedCrossRefGoogle Scholar
  40. 40.
    Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288(3):321–333PubMedCrossRefGoogle Scholar
  41. 41.
    The North American Menopause Society (2004) Recommendations for estrogen and progestogen use in peri-and postmenopausal women: October 2004 position statement of The North American Menopause Society. Menopause 11(6 Pt 1):589–600Google Scholar
  42. 42.
    Stafford RS, Drieling RL, Hersh AL (2004) National trends in osteoporosis visits and osteoporosis treatment, 1988–2003. Arch Intern Med 164(14):1525–1530PubMedCrossRefGoogle Scholar
  43. 43.
    Holick M (2006) High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81(3):353–373PubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2007

Authors and Affiliations

  • T. W. Weiss
    • 1
  • E. S. Siris
    • 2
  • E. Barrett-Connor
    • 3
  • P. D. Miller
    • 4
  • C. A. McHorney
    • 1
  1. 1.US Outcomes Research, Merck & Co. Inc.West PointUSA
  2. 2.Columbia University College of Physicians and SurgeonsNew YorkUSA
  3. 3.University of CaliforniaSan Diego, La JollaUSA
  4. 4.Colorado Center for Bone ResearchLakewoodUSA

Personalised recommendations